Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Hiltraud Kajüter"'
Autor:
Kevin Claaßen, Madeleine Karpinski, Hiltraud Kajüter, Johannes Hüsing, Lennart Möller, Ina Wellmann, Viktor Grünwald, Boris Hadaschik, Peter Albers, Andreas Stang
Publikováno v:
BMC Urology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The crude mortality rate and the lifetime mortality risk from prostate cancer in Germany are above international average. However age-standardised mortality and years of life lost per capita from prostate cancer are declining. Thi
Externí odkaz:
https://doaj.org/article/c63f78473323475196a6089bc91729ea
Autor:
Christine Eisfeld, Hiltraud Kajüter, Lennart Möller, Ina Wellmann, Evgenii Shumilov, Andreas Stang
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Steady evolution of therapies has improved prognosis of patients with multiple myeloma (MM) over the past two decades. Yet, knowledge about survival trends and causes of death in MM might play a crucial role in long-term managemen
Externí odkaz:
https://doaj.org/article/258eefa935a04e8f9b8a7d0b4b7a8d7c
Autor:
Hiltraud Kajüter, Ina Wellmann, Laura Khil, Karl-Heinz Jöckel, Can Zhang, Anna-Maria Fink, Michael Hallek, Andreas Stang
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 10, Pp 1-4 (2021)
Abstract Chronic lymphocytic leukemia (CLL) is the most common leukemia of adults in western countries. Therapy is indicated in symptomatic and advanced stages and has changed fundamentally since 2010 when rituximab, an anti-CD20 antibody, has been a
Externí odkaz:
https://doaj.org/article/c0c381b4da6f4481b15b0d803fccb8d1
Autor:
Simone Kaucher, Laura Khil, Hiltraud Kajüter, Heiko Becher, Maren Reder, Petra Kolip, Jacob Spallek, Volker Winkler, Eva-Maria Berens
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background European studies showed that women with a migration background are less likely to participate in mammography screenings than autochthonous women. However, the participation in the German mammography screening programme (MSP) among
Externí odkaz:
https://doaj.org/article/13aafd813aed4ee0a7df1248d0206a04
Autor:
Philipp Jaehn, Simone Kaucher, Lidia V. Pikalova, Sofia Mazeina, Hiltraud Kajüter, Heiko Becher, Mikhail Valkov, Volker Winkler
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Few studies compared cancer incidence among migrants both to their host countries and to their population of origin. We aimed to compare cancer incidence of ethnic Germans who migrated from the former Soviet Union to Germany (rese
Externí odkaz:
https://doaj.org/article/8712dc72ed9e4f0d8f27be0775da63b6
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Germany is a country known for immigration. In 2015, 21% of the general population in Germany consisted of individuals with a migration background. This article focuses on cancer-specific incidence and mortality among one of the biggest migrant group
Externí odkaz:
https://doaj.org/article/9883d3e545254612a68f48f6ec68b165
Autor:
Andreas Stang, Pietro Trocchi, Hiltraud Kajüter, Britton Trabert, J. Wolter Oosterhuis, Katherine A. McGlynn
Publikováno v:
Andrology, 11(1), 65-72. John Wiley & Sons Inc.
Background & objectives: The comparison of the incidence of gonadal germ cell tumors among males and females can provide insights that cannot be gained by separately studying these tumors. Material and methods: Incidence data on male and female gonad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ac028ea60f269f67e2ff04deb911a64
https://doi.org/10.1111/andr.13282
https://doi.org/10.1111/andr.13282
Autor:
Christopher Darr, Lennart Möller, Niklas Schürger, Tibor Szarvas, Henning Reis, Andreas Stang, Boris A. Hadaschik, Hiltraud Kajüter, Viktor Grünwald
Publikováno v:
Journal of Clinical Oncology. 41:480-480
480 Background: Urachal carcinoma (UrC) is a rare and poorly studied cancer without evidence-based treatment strategies. Due to the low prevalence of this cancer, only sparse data on its incidence and survival are available. Therefore, we analyzed th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5f489254eb73eb26b0d5df26938a69a
https://doi.org/10.1200/jco.2023.41.6_suppl.480
https://doi.org/10.1200/jco.2023.41.6_suppl.480
Autor:
Laura Khil, Can Zhang, Karl-Heinz Jöckel, Anna-Maria Fink, Andreas Stang, I. Wellmann, Hiltraud Kajüter, Michael Hallek
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 11, Iss 10, Pp 1-4 (2021)
Blood Cancer Journal, Vol 11, Iss 10, Pp 1-4 (2021)
Chronic lymphocytic leukemia (CLL) is the most common leukemia of adults in western countries. Therapy is indicated in symptomatic and advanced stages and has changed fundamentally since 2010 when rituximab, an anti-CD20 antibody, has been approved f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be782c97c29071cb014faf33f9b87048
http://europepmc.org/articles/PMC8556420
http://europepmc.org/articles/PMC8556420